IDXG insider trading
OTC Markets OTCPK HealthcareINTERPACE BIOSCIENCES, INC.: insider trade history from SEC Form 4 filings.
About INTERPACE BIOSCIENCES, INC.
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis of pancreaticobiliary cancers using its proprietary PathFinderTG platform; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. The company also provides ThyraMIR v2, which assesses thyroid nodules for malignancy risk using a proprietary microRNA gene expression classifier; and RespriDx, a genomic test that enables physicians to differentiate metastatic or recurrent lung cancer. It primarily serves physicians, cancer centers, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Company website: www.interpace.com
IDXG insider activity at a glance
FilingIQ tracks 41 insider transactions for IDXG in filings since Dec 30, 2015. The most recent transaction is dated Aug 20, 2026.
Across the full history, 9 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on IDXG insider trades is 43.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest IDXG Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for IDXG?
- FilingIQ tracks 41 Form 4 insider transactions for IDXG (INTERPACE BIOSCIENCES, INC.), covering filings from Dec 30, 2015 onwards. 3 of those are dated within the last 90 days.
- Are IDXG insiders net buyers or net sellers?
- Across the full Form 4 history for IDXG, 9 transactions (22%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does IDXG insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is IDXG in?
- INTERPACE BIOSCIENCES, INC. (IDXG) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $51.24M.
Methodology & sources
Every IDXG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.